Invus Global Management, LLC 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-20 10:37 am Purchase | 2026-03-16 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Invus Global Management, LLC | 4,461,949 5.100% | 4,461,949 (New Position) | Filing |